Big frenzy in big pharma: What's happening and why  - Marketintelligencecenter.com

Big frenzy in big pharma: What's happening and why


Traders returned from the long Easter weekend to discover news that the pharma supergiant Pfizer had made a $101 billion offer for mere pharma giant, AstraZeneca (AZN). The deal was rejected, but talks may be continuing, as we reported yesterday. What is now clear is that the deal signaled other companies in the big pharma industry that the gates were open, and it was time to act lest their own deals be shut out, hence, just 24 hours later, we have two more huge 11-digit deals to report on in addition to the one colossal 12-digit deal. Wading... Read More



Recent News

Stocks closed higher again Tuesday, stretching the S&P 500's winning streak to 6 days. The NASDAQ was the leading gainer among the major...

Traders returned from the long Easter weekend to discover news that the pharma supergiant Pfizer had made a $101 billion offer for mere pharma giant...

Americans have been tempted away from their usual McDonald's (MCD) breakfast by the primal appeal of Taco Bell's new waffle-taco. If you...

BancorpSouth, Inc.’s (BXS) first-quarter 2014 earnings per share came in at 30 cents, in line with the Zacks Consensus Estimate. However...

The 2014 Q1 reporting season peaks this week, with almost 600 companies reporting results, including 154 S&P 500 companies. It has been an...


Portions of this content may be copyright by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. SmartReadMX and other related technologies used to produce content for this service are covered by US Patents numbers 7,865,496, 7,856,390, and 7,716,116.

Get the MarketIntelligenceCenter Newsletter

The most important market news delivered to your inbox every morning!

Click here to see the latest newsletter


Enter your email address:

  No thank you